Triglyceride-glucose index is associated with symptomatic coronary artery disease in patients in secondary care.
Alessandra da SilvaAna Paula Silva CaldasHelen Hermana Miranda HermsdorffÂngela Cristine Bersch-FerreiraCamila Ragne TorreglosaBernardete WeberJosefina BressanPublished in: Cardiovascular diabetology (2019)
The TyG index was positively associated with a higher prevalence of symptomatic CAD, with metabolic and behavioral risk factors, and could be used as a marker for atherosclerosis. Trial registration ClinicalTrials.gov identifier: NCT01620398. Registered 15 June, 2012.
Keyphrases
- coronary artery disease
- risk factors
- end stage renal disease
- healthcare
- newly diagnosed
- ejection fraction
- chronic kidney disease
- clinical trial
- palliative care
- cardiovascular disease
- study protocol
- peritoneal dialysis
- quality improvement
- randomized controlled trial
- blood glucose
- heart failure
- coronary artery bypass grafting
- phase iii
- phase ii
- acute coronary syndrome
- affordable care act
- aortic valve
- health insurance